Page 89 - Read Online

Page 14 of 18 Billings et al. Plast Aesthet Res. 2025;12:27 https://dx.doi.org/10.20517/2347-9264.2025.52

38. Deutsch MB. Gender-affirming surgeries in the era of insurance coverage: developing a framework for psychosocial support and care
navigation in the perioperative period. J Health Care Poor Underserved. 2016;27:386-91. DOI PubMed
39. Selvaggi G, Giordano S. The role of mental health professionals in gender reassignment surgeries: unjust discrimination or
responsible care? Aesthetic Plast Surg. 2014;38:1177-83. DOI PubMed
40. T'Sjoen G, Arcelus J, De Vries ALC, et al. European Society for Sexual Medicine position statement “Assessment and hormonal
management in adolescent and adult trans people, with attention for sexual function and satisfaction”. J Sex Med. 2020;17:570-84.
DOI PubMed
41. Baker KE, Wilson LM, Sharma R, Dukhanin V, McArthur K, Robinson KA. Hormone therapy, mental health, and quality of life
among transgender people: a systematic review. J Endocr Soc. 2021;5:bvab011. DOI PubMed PMC
42. Reisner SL, Pletta DR, Keuroghlian AS, et al. Gender-affirming hormone therapy and depressive symptoms among transgender
adults. JAMA Netw Open. 2025;8:e250955. DOI PubMed PMC
43. Turban JL, King D, Kobe J, Reisner SL, Keuroghlian AS. Access to gender-affirming hormones during adolescence and mental
health outcomes among transgender adults. PLoS One. 2022;17:e0261039. DOI PubMed PMC
44. Tordoff DM, Wanta JW, Collin A, Stepney C, Inwards-Breland DJ, Ahrens K. Mental health outcomes in transgender and nonbinary
youths receiving gender-affirming care. JAMA Netw Open. 2022;5:e220978. DOI PubMed PMC
45. Chen D, Berona J, Chan YM, et al. Psychosocial functioning in transgender youth after 2 years of hormones. N Engl J Med.
2023;388:240-50. DOI PubMed PMC
46. Green AE, DeChants JP, Price MN, Davis CK. Association of gender-affirming hormone therapy with depression, thoughts of
suicide, and attempted suicide among transgender and nonbinary youth. J Adolesc Health. 2022;70:643-9. DOI PubMed
47. Fisher AD, Castellini G, Ristori J, et al. Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year
follow-up data. J Clin Endocrinol Metab. 2016;101:4260-9. DOI PubMed
48. Defreyne J, Elaut E, Kreukels B, et al. Sexual desire changes in transgender individuals upon initiation of hormone treatment: results
from the longitudinal european network for the investigation of gender incongruence. J Sex Med. 2020;17:812-25. DOI PubMed
49. T'Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V. Endocrinology of transgender medicine. Endocr Rev. 2019;40:97-117.
DOI PubMed
50. Tordoff DM, Lunn MR, Chen B, et al. Testosterone use and sexual function among transgender men and gender diverse people
assigned female at birth. Am J Obstet Gynecol. 2023;229:669.e1-17. DOI PubMed PMC
51. Deutsch M. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. Available from:
https://transcare.ucsf.edu/guidelines. [Last accessed on 25 Aug 2025].
52. Adeleye AJ, Reid G, Kao CN, Mok-Lin E, Smith JF. Semen parameters among transgender women with a history of hormonal
treatment. Urology. 2019;124:136-41. DOI PubMed
53. Kozato A, Fox GWC, Yong PC, et al. No venous thromboembolism increase among transgender female patients remaining on
estrogen for gender-affirming surgery. J Clin Endocrinol Metab. 2021;106:e1586-90. DOI PubMed
54. Wu SS, Raymer CA, Kaufman BR, Isakov R, Ferrando CA. The effect of preoperative gender-affirming hormone therapy use on
perioperative adverse events in transmasculine individuals undergoing masculinizing chest surgery for gender affirmation. Aesthet
Surg J. 2022;42:1009-16. DOI PubMed
55. Rysin R, Skorochod R, Wolf Y. Implications of testosterone therapy on wound healing and operative outcomes of gender-affirming
chest masculinization surgery. J Plast Reconstr Aesthet Surg. 2023;81:34-41. DOI PubMed
56. Robinson IS, Rifkin WJ, Kloer C, et al. Perioperative hormone management in gender-affirming mastectomy: is stopping testosterone
before top surgery really necessary? Plast Reconstr Surg. 2023;151:421-7. DOI PubMed
57. Finegan JL, Marinkovic M, Okamuro K, Newfield RS, Anger JT. Experience with gender affirming hormones and puberty blockers
(gonadotropin releasing hormone agonist): a qualitative analysis of sexual function. J Sex Med. 2025;22:945-50. DOI PubMed
58. van der Meulen IS, Bungener SL, van der Miesen AIR, et al. Timing of puberty suppression in transgender adolescents and sexual
functioning after vaginoplasty. J Sex Med. 2025;22:196-204. DOI PubMed
59. Bekeny JC, Zolper EG, Fan KL, Del Corral G. Breast augmentation for transfeminine patients: methods, complications, and
outcomes. Gland Surg. 2020;9:788-96. DOI PubMed PMC
60. Morrison SD, Wilson SC, Mosser SW. Breast and body contouring for transgender and gender nonconforming individuals. Clin Plast
Surg. 2018;45:333-42. DOI PubMed
61. Fisher M, Lu SM, Chen K, Zhang B, Di Maggio M, Bradley JP. Facial feminization surgery changes perception of patient gender.
Aesthet Surg J. 2020;40:703-9. DOI PubMed
62. Boskey ER, Mehra G, Jolly D, Ganor O. Concerns about internal erectile prostheses among transgender men who have undergone
phalloplasty. J Sex Med. 2022;19:1055-9. DOI PubMed
63. Hale ES, Gibstein AR, Smartz T, Boghosian T, Jabori SK, Danker S. Chest feminization and masculinization surgery: part two of the
plastic surgeon's perspective of gender-affirming surgery. Plast Aesthet Nurs. 2025;45:27-33. DOI PubMed
64. Wolf Y, Kwartin S. Classification of transgender man’s breast for optimizing chest masculinizing gender-affirming surgery. Plast
Reconstr Surg Glob Open. 2021;9:e3363. DOI PubMed PMC
65. Bustos VP, Bustos SS, Mascaro A, et al. Transgender and gender-nonbinary patient satisfaction after transmasculine chest surgery.
Plast Reconstr Surg Glob Open. 2021;9:e3479. DOI PubMed PMC
66. Claes KEY, D’Arpa S, Monstrey SJ. Chest surgery for transgender and gender nonconforming individuals. Clin Plast Surg.